Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teng-Yu Lee

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 11, 2018
The choice of antiviral therapy for hepatitis C recurrence after liver transplantation in the real worldTeng-Yu Lee, Sheng-Shun Yang
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 20, 2021
ReplyTeng-Yu Lee, Chun-Ying Wu
Clinical and Molecular Hepatology|January 27, 2026
Aspirin on the prevention of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver diseaseTeng-Yu Lee, Chun-Ying Wu
Digestive Diseases and Sciences|December 4, 2008
Independent factors associated with recurrent bleeding in cirrhotic patients with esophageal variceal hemorrhageShou-Wu Lee, Teng-Yu Lee, Chi-Sen Chang
Alimentary Pharmacology & Therapeutics|March 7, 2026
Letter: Methodological Considerations in Interpreting Polygenic Risk Scores for Hepatocellular Carcinoma After SVR. Authors' ReplyYu-Sheng Lin, Yun-Yu Chen, Teng-Yu Lee
Gastroenterology Research|March 11, 2024
A Real-World Experience on a Chinese Population of Patients With Unresectable Hepatocellular Carcinoma Treated With NivolumabShou-Wu Lee, Sheng-Shun Yang, Teng-Yu Lee
Alimentary Pharmacology & Therapeutics|March 27, 2026
Letter: Beyond Association: Operationalizing PRS-5 for Hepatocellular Carcinoma Surveillance. Authors' ReplyYu-Sheng Lin, Ying-Cheng Lin, Teng-Yu Lee
European Journal of Cancer (Oxford, England : 1990)|March 25, 2020
Hepatitis B flare during osimertinib targeted therapy in a lung cancer patient with a resolved hepatitis B virus infectionPo-Hsin Lee, Teng-Yu Lee, Gee-Chen Chang
World Journal of Hepatology|September 30, 2025
Targeting glypican-3 as a new frontier in liver cancer therapyChen-Shiou Wu, Teng-Yu Lee, Hsu-Wen Chao
Alimentary Pharmacology & Therapeutics|March 18, 2026
Editorial: Residual HCC Risk After Hepatitis C Cure-Can Polygenic Risk Scores Refine Surveillance? Authors' ReplyYu-Sheng Lin, Hwai-I Yang, Teng-Yu Lee
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 11, 2018
The choice of antiviral therapy for hepatitis C recurrence after liver transplantation in the real worldTeng-Yu Lee, Sheng-Shun Yang
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 20, 2021
ReplyTeng-Yu Lee, Chun-Ying Wu
Clinical and Molecular Hepatology|January 27, 2026
Aspirin on the prevention of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver diseaseTeng-Yu Lee, Chun-Ying Wu
Digestive Diseases and Sciences|December 4, 2008
Independent factors associated with recurrent bleeding in cirrhotic patients with esophageal variceal hemorrhageShou-Wu Lee, Teng-Yu Lee, Chi-Sen Chang
Alimentary Pharmacology & Therapeutics|March 7, 2026
Letter: Methodological Considerations in Interpreting Polygenic Risk Scores for Hepatocellular Carcinoma After SVR. Authors' ReplyYu-Sheng Lin, Yun-Yu Chen, Teng-Yu Lee
Gastroenterology Research|March 11, 2024
A Real-World Experience on a Chinese Population of Patients With Unresectable Hepatocellular Carcinoma Treated With NivolumabShou-Wu Lee, Sheng-Shun Yang, Teng-Yu Lee
Alimentary Pharmacology & Therapeutics|March 27, 2026
Letter: Beyond Association: Operationalizing PRS-5 for Hepatocellular Carcinoma Surveillance. Authors' ReplyYu-Sheng Lin, Ying-Cheng Lin, Teng-Yu Lee
European Journal of Cancer (Oxford, England : 1990)|March 25, 2020
Hepatitis B flare during osimertinib targeted therapy in a lung cancer patient with a resolved hepatitis B virus infectionPo-Hsin Lee, Teng-Yu Lee, Gee-Chen Chang
World Journal of Hepatology|September 30, 2025
Targeting glypican-3 as a new frontier in liver cancer therapyChen-Shiou Wu, Teng-Yu Lee, Hsu-Wen Chao
Alimentary Pharmacology & Therapeutics|March 18, 2026
Editorial: Residual HCC Risk After Hepatitis C Cure-Can Polygenic Risk Scores Refine Surveillance? Authors' ReplyYu-Sheng Lin, Hwai-I Yang, Teng-Yu Lee
Pageof 13